Skip to content
Clinical Trials – home
CyprusBack to Cyprus

Clinical trials in Agios Dometios

7 clinical trials in Agios Dometios, Cyprus. Every trial is listed in the EU Clinical Trials Register and updated daily.

Agios Dometios at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Agios Dometios

Open in trial search
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Eplontersen
  • Sponsor:Ionis Pharmaceuticals Inc.
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Cardiac amyloidosis+1

Not recruiting
Registered drug
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Patisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx

Other cities in Cyprus

The busiest research cities in the country

All 4 cities in Cyprus

Clinical research in Agios Dometios

What the registry says about research in the country

01 Myasthenia Research

Innovative clinical studies focusing on Ocular Myasthenia Gravis and Generalized Myasthenia Gravis, evaluating new therapeutic approaches using efgartigimod in different formulations. These trials aim to improve treatment options for patients with varying presentations of the condition.

  • Ocular Myasthenia Gravis Treatment
  • Seronegative MG Therapies
  • Subcutaneous Treatment Development

Research emphasizes both efficacy and safety profiles in different patient populations.

02 Inflammatory Myopathy Studies

Comprehensive research into Idiopathic Inflammatory Myopathy, investigating both short-term and long-term treatment outcomes. These trials evaluate novel therapeutic approaches while maintaining established immunomodulatory therapies.

  • Long-term Safety Assessment
  • Treatment Efficacy Evaluation
  • Combined Therapy Approaches

Studies focus on developing sustainable treatment options for chronic inflammatory conditions.

03 Amyloidosis Research

Groundbreaking studies on Hereditary Transthyretin Amyloidosis, including investigations of new compounds targeting neurologic impairment. The research encompasses both established and innovative therapeutic approaches.

  • Polyneuropathy Treatment
  • Novel Therapeutic Compounds
  • Extended Treatment Protocols

These trials aim to advance treatment options for patients with hereditary amyloid disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).